Doxepin Hydrochloride Capsule
Product Images NDC 70518-3767

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Doxepin Hydrochloride (NDC 70518-3767). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Remedy_label (Remedy Label)

Remedy_label (Remedy Label)
Doxepin HCI is a medication available in the form of 50 mg capsules. The package contains 30 capsules. It is important to protect the capsules from light. The medication is only available with a prescription. The NDC number for the medication is 70518-3767-00. The lot number and expiration date are not provided in the text. The source NDC for the medication is 27241-0169-01, and it is manufactured by Ajanta Pharma Ltd in Paithan, India. It is important to keep this medication out of the reach of children. The directions for use can be found in the package insert. The medication should be stored at a temperature of 20-25°C (68-77°F), with excursions permitted between 15-30°C (59-86°F) as per USP guidelines. The medication has been repackaged by RemedyRepack Inc.*
FDA Label Image

Doxepin-structure (Doxepin Structure)

Doxepin-structure (Doxepin Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.